Mountain Crest Acquisition Corp. V has filed a supplement to its proxy statement, which reveals important updates regarding its upcoming business combination. The filing, dated November 3, 2026, is significant as it informs shareholders of a name change for its business partner, CubeBio Holdings Limited, which will now be known as VIANIQ Holdings Limited. This change is part of the preparations for a special meeting scheduled for November 11, 2026.

The filing also notes that the proposed Nasdaq ticker symbol for the company will change from 'KUBE' to 'VIAN' in connection with the closing of the business combination. This adjustment reflects the new branding and is aimed at aligning the company's identity with its future operations.

Background

Mountain Crest Acquisition Corp. V is a company focused on the surgical and medical instruments and apparatus sector, classified under SIC code 3841. The company operates on the OTC exchange with ticker symbols MCAG, MCAGR, and MCAGU. Recent filings include a definitive proxy statement and other related documents that outline the company's plans and updates.

What the Filing Says

The filing states, "The purpose of this Supplement is to disclose the change of name of CubeBio Holdings Limited... to 'VIANIQ Holdings Limited.'" It further clarifies that the change does not affect the terms of the proposed business combination and that all references to CubeBio Holdings Limited will now refer to VIANIQ Holdings Limited.

Impact

This name change and the adjustment of the ticker symbol may affect shareholders and potential investors as they prepare for the special meeting. The update aims to ensure that all stakeholders are informed of the latest developments as the company moves forward with its business combination.

What's Next

The special meeting of stockholders will take place on November 11, 2026, at 11:00 a.m. Eastern Time. Shareholders are encouraged to vote on the proposals as recommended by the company's board of directors. The filing confirms that there are no changes to the meeting schedule or proposals, and the deadline for redemption requests remains set for November 9, 2026.